心泰醫療(02291.HK):RF-Lance一次性使用射頻房間隔穿刺針取得醫療器械登記證
格隆匯7月25日丨心泰醫療(02291.HK)發佈公吿,公司的全資附屬公司上海形狀記憶合金材料有限公司已取得中國國家藥品監督管理局就RF-Lance一次性使用射頻房間隔穿刺針產品(RF-Lance一次性使用射頻房間隔穿刺針)授出的醫療器械註冊證。
RF-Lance一次性使用射頻房間隔穿刺針的成功獲批,不僅豐富了公司在心臟介入通路管線的產品組合,也為公司在該領域的持續發展奠定了堅實基礎。未來,公司將秉承初心,堅持創新驅動發展,深耕結構性心臟病領域的同時,探索更廣泛的醫療應用場景,通過持續的技術創新和產品優化升級,帶來更先進、安全有效的解決方案,更好地服務臨牀,造福廣大患者。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.